BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11445797)

  • 21. C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients.
    Caforio AL; Tona F; Piaserico S; Gambino A; Feltrin G; Fortina AB; Angelini A; Alaibac M; Bontorin M; Calzolari D; Peserico A; Thiene G; Iliceto S; Gerosa G
    Transpl Int; 2005 Jan; 18(1):116-24. PubMed ID: 15612993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality of life in adult survivors greater than 10 years after pediatric heart transplantation.
    Petroski RA; Grady KL; Rodgers S; Backer CL; Kulikowska A; Canter C; Pahl E
    J Heart Lung Transplant; 2009 Jul; 28(7):661-6. PubMed ID: 19560692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten- and 20-year survivors of pediatric orthotopic heart transplantation.
    Ross M; Kouretas P; Gamberg P; Miller J; Burge M; Reitz B; Robbins R; Chin C; Bernstein D
    J Heart Lung Transplant; 2006 Mar; 25(3):261-70. PubMed ID: 16507417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of renal function in pediatric heart transplant recipients: long-term follow-up study.
    Sachdeva R; Blaszak RT; Ainley KA; Parker JG; Morrow WR; Frazier EA
    J Heart Lung Transplant; 2007 Feb; 26(2):108-13. PubMed ID: 17258142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
    Barnard JB; Thekkudan J; Richardson S; Bittar MN; Martyszczuck R; Hasan J; Khasati N; Keevil B; Yonan N
    J Heart Lung Transplant; 2006 May; 25(5):564-8. PubMed ID: 16678036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
    Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
    Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up after conversion to Neoral in stable heart transplant recipients.
    Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T
    Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226
    [No Abstract]   [Full Text] [Related]  

  • 32. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
    Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
    J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
    Akhlaghi F; Gonzalez L; Trull AK
    J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-adherence to post-transplant care: prevalence, risk factors and outcomes in adolescent liver transplant recipients.
    Berquist RK; Berquist WE; Esquivel CO; Cox KL; Wayman KI; Litt IF
    Pediatr Transplant; 2008 Mar; 12(2):194-200. PubMed ID: 18307668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
    Lietz K; John R; Mancini DM; Edwards NM
    J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-compliance in children post-liver transplant. Who are the culprits?
    Falkenstein K; Flynn L; Kirkpatrick B; Casa-Melley A; Dunn S
    Pediatr Transplant; 2004 Jun; 8(3):233-6. PubMed ID: 15176959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.